Recent Quotes (30 days)

You have no recent quotes
chg | %

C R Bard Inc  

(Public, NYSE:BCR)   Watch this stock  
Find more results for BCR
- Close
NYSE real-time data - Disclaimer
Currency in
Range     -
52 week 223.02 - 337.73
Open     -
Vol. 0.00
Mkt cap 24.14B
P/E 0.00
Div/yield 0.26/∞
EPS 7.59
Shares 72.89M
Beta 0.52
Inst. own 82%

Key stats and ratios

Q3 (Sep. '17) 2016
Net profit margin 9.51% 14.31%
Operating margin 13.12% 19.25%
EBITD margin - 31.42%
Return on average assets 6.91% 10.47%
Return on average equity 19.39% 33.78%
Employees 16,300 -
CDP Score - -


730 Central Ave
United States - Map
+1-908-2778000 (Phone)
+1-908-2778412 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


C. R. Bard, Inc. (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. Its vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and end-stage renal disease. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers, and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and soft tissue repairs.